# A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections

> **NCT00647907** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 7 (actual)

## Conditions studied

- Candidiasis
- Cryptococcosis
- Aspergillosis

## Interventions

- **DRUG:** Voriconazole

## Key facts

- **NCT ID:** NCT00647907
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** —
- **Final completion:** 2004-05
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2011-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00647907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00647907, "A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00647907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*